Grand Rounds
  Most Recent Cases
  Dates of Case
  Type of Case
  Submit a Grand Round.
  Register with DJO to receive personalized updates.

If you're already a
member, please sign in.
20 year old Hispanic woman with bilateral blurry vision, nausea, weakness and severe headaches
Digital Journal of Ophthalmology 2005
Volume 11, Number 11
July 10, 2005
Printer Friendly



Szilard Kiss | Massachusetts Eye and Ear Infirmary
References
Read RW. Vogt-Koyanagi-Harada disease. Ophthalmol Clin North Am 2002;15:333-41.

Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1980;90:69-75.

Nussenblatt RB. Clinical studies of Vogt-Koyanagi-Harada's disease at the National Eye Institute, NIH, USA. Jpn J Ophthalmol 1988;32:330-3.

Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991;109:682-7.

Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 1988;32:334-43.

Sasamoto Y, Ohno S, Matsuda H. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica 1990;201:162-7.

Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-52.

Kamondi A, Szegedi A, Papp A, Seres A, Szirmai I. Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis. Eur J Neurol 2000;7:719-22.

Goto H, Rao NA. Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin 1990;30:279-85.

Lubin JR, Ni C, Albert DM. Clinicopathological study of the Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin 1982l;22:141-56.

Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 1994;78:223-6.

Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK Marin ML, Hammer J, Kalil J, Yamamoto JH. T cell recognition and cytokine profile induced by melanocyte epitopes in HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis patients. Invest Ophthalmol Vis Sci. [in press]2005.

Chan CC, Palestine AG, Nussenblatt RB, Roberge FG, Benezra D. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology 1985;92:1025-8.

Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995;39:265-92.

Oshima Y, Harino S, Hara Y, Tano Y. Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 1996;122:58-66.

Read RW, VKH Therapy Group. Poster 2664: A retrospective multinational survey of current treatment patterns in acute and subacute Vogt-Koyanagi-Harada disease. 2004 Association for Research in Vision and Ophthalmology Annual Meeting. Fort Lauderdale, FL, April 25-29.

Paredes IP, Ahmed M, Foster CS. Poster 2663: Immunomodulatory therapy for VKH patients as a first line therapy. 2004 Association for Research in Vision and Ophthalmology Annual Meeting. Fort Lauderdale, FL, April 25-29.

Wakatsuki Y, Kogure M, Takahashi Y, Oguro Y. Combination therapy with cyclosporin A and steroid in severe case of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 1988;32:358-60.

Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, Rao NA. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001;131:599-606.
top